Laboratory Compliance: AKS and EKRA
During this video lecture, you will hear from legal experts regarding the Anti-Kickback Statute (AKS) and the Eliminating Kickbacks in Recovery Act (EKRA) along with recent relevant court cases.
Originally published on November 7, 2022
Lecture Presenters
Jonathan Carr, JD Compliance Officer |
Jonathan Carr is the compliance officer at ARUP Laboratories. He graduated from Brigham Young University with a bachelor’s degree in biology and then graduated from Florida State University College of Law. Carr is a registered patent attorney, a certified international privacy professional, and a member of the Utah and Florida state bars. Carr is also a member of the Risk and Insurance Management Society and the Health Care Compliance Association.
Elizabeth Sullivan, JD Chair, Healthcare Practice Group |
Elizabeth Sullivan is chair of McDonald Hopkins' Healthcare Practice group and a member of the firm's board of directors. She began her legal career in the Healthcare Practice group at McDonald Hopkins and later served as an attorney in the legal department at The Cleveland Clinic Foundation before returning to McDonald Hopkins as a member. Sullivan earned a JD and Certificate of Advanced Studies in Health Law from the University of Pittsburgh School of Law, an MA in bioethics and a BA, cum laude, in political science from Case Western Reserve University.
Emily A. Johnson, JD
|
Emily Johnson focuses her practice on matters primarily for clients in the healthcare industry. She provides regulatory and compliance assistance on both a federal and state level. She has assisted clinical laboratories, hospitals, long-term acute care hospitals, community hospitals, physician specialty groups, telehealth providers, surgery centers, healthcare associations, pharmacies, and other healthcare providers on regulatory, licensing, compliance, reimbursement, contractual, and corporate matters. Johnson earned a JD from The John Marshall Law School in 2010. She received a BA, Dean's List, from Illinois Wesleyan University in 2005.
Objectives
After this presentation, participants will be able to:
- Describe the basic intent of, and penalties for violation of, EKRA
- Identify differences between AKS and EKRA
- Recognize the basic concepts and key issues in recent court cases involving EKRA
Sponsored by:
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories